DADC
TEVA icon

D.A. Davidson & Co’s Teva Pharmaceuticals TEVA Stock Holding History

D.A. Davidson & Co’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.05M Sell
101,274
-3,646
-3% -$117K 0.02% 552
2025
Q4 		$3.27M Buy
104,920
+13,844
+15% +$341K 0.02% 506
2025
Q3 		$1.84M Buy
91,076
+1,918
+2% +$33.7K 0.01% 666
2025
Q2 		$1.49M Sell
89,158
-5,428
-6% -$87.6K 0.01% 694
2025
Q1 		$1.45M Buy
94,586
+5,667
+6% +$101K 0.01% 664
2024
Q4 		$1.96M Buy
88,919
+2,408
+3% +$43.8K 0.02% 571
2024
Q3 		$1.56M Buy
86,511
+5,257
+6% +$92K 0.01% 632
2024
Q2 		$1.32M Buy
81,254
+10,631
+15% +$164K 0.01% 647
2024
Q1 		$996K Buy
70,623
+49,054
+227% +$618K 0.01% 741
2023
Q4 		$225K Sell
21,569
-395
-2% -$3.69K ﹤0.01% 1209
2023
Q3 		$224K Hold
21,964
– – ﹤0.01% 1186
2023
Q2 		$165K Hold
21,964
– – ﹤0.01% 1252
2023
Q1 		$194K Sell
21,964
-500
-2% -$4.94K ﹤0.01% 1234
2022
Q4 		$205K Sell
22,464
-400
-2% -$3.49K ﹤0.01% 1186
2022
Q3 		$185K Buy
22,864
+2,559
+13% +$22.6K ﹤0.01% 1171
2022
Q2 		$153K Sell
20,305
-1,495
-7% -$13K ﹤0.01% 1190
2022
Q1 		$205K Buy
21,800
+187
+0.9% +$1.56K ﹤0.01% 1203
2021
Q4 		$173K Sell
21,613
-2,109
-9% -$19K ﹤0.01% 1209
2021
Q3 		$231K Sell
23,722
-1,600
-6% -$15K ﹤0.01% 1102
2021
Q2 		$251K Sell
25,322
-1,396
-5% -$14.8K ﹤0.01% 1060
2021
Q1 		$308K Buy
26,718
+2,611
+11% +$29.9K ﹤0.01% 952
2020
Q4 		$233K Sell
24,107
-1,805
-7% -$17.3K ﹤0.01% 929
2020
Q3 		$233K Sell
25,912
-1,087
-4% -$11.5K ﹤0.01% 828
2020
Q2 		$333K Sell
26,999
-4,661
-15% -$52.7K 0.01% 720
2020
Q1 		$284K Sell
31,660
-385
-1% -$3.94K 0.01% 764
2019
Q4 		$314K Buy
32,045
+1,251
+4% +$11.2K 0.01% 805
2019
Q3 		$212K Sell
30,794
-2,350
-7% -$18K ﹤0.01% 904
2019
Q2 		$306K Sell
33,144
-14,623
-31% -$176K 0.01% 778
2019
Q1 		$747K Sell
47,767
-2,998
-6% -$52.9K 0.01% 573
2018
Q4 		$783K Sell
50,765
-274
-0.5% -$5.62K 0.02% 536
2018
Q3 		$1.1M Buy
51,039
+1,544
+3% +$35.8K 0.02% 487
2018
Q2 		$1.2M Buy
49,495
+721
+1% +$14.7K 0.02% 454
2018
Q1 		$834K Sell
48,774
-5,065
-9% -$98.9K 0.02% 514
2017
Q4 		$1.02M Sell
53,839
-10,824
-17% -$163K 0.02% 458
2017
Q3 		$1.14M Sell
64,663
-201,758
-76% -$4.54M 0.02% 469
2017
Q2 		$8.85M Buy
266,421
+52,048
+24% +$1.61M 0.2% 92
2017
Q1 		$6.88M Buy
214,373
+41,779
+24% +$1.43M 0.17% 109
2016
Q4 		$6.25M Buy
172,594
+132,995
+336% +$5.31M 0.14% 146
2016
Q3 		$1.82M Buy
39,599
+13,270
+50% +$692K 0.05% 346
2016
Q2 		$1.32M Buy
26,329
+630
+2% +$33.5K 0.04% 351
2016
Q1 		$1.37M Sell
25,699
-1,847
-7% -$108K 0.04% 351
2015
Q4 		$1.8M Sell
27,546
-409
-1% -$25.3K 0.06% 293
2015
Q3 		$1.57M Buy
27,955
+309
+1% +$20K 0.06% 305
2015
Q2 		$1.63M Sell
27,646
-31,882
-54% -$1.97M 0.05% 309
2015
Q1 		$3.71M Sell
59,528
-2,411
-4% -$140K 0.12% 175
2014
Q4 		$3.56M Buy
61,939
+2,778
+5% +$155K 0.12% 181
2014
Q3 		$3.18M Sell
59,161
-2,812
-5% -$149K 0.11% 189
2014
Q2 		$3.24M Sell
61,973
-7,489
-11% -$383K 0.11% 183
2014
Q1 		$3.67M Sell
69,462
-44,290
-39% -$2.05M 0.13% 156
2013
Q4 		$4.56M Sell
113,752
-143,832
-56% -$5.66M 0.17% 119
2013
Q3 		$9.73M Buy
257,584
+686
+0.3% +$26.8K 0.44% 48
2013
Q2 		$10.1M Buy
+256,898
New +$10M 0.49% 40

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.A. Davidson & Co's TEVA Position: Q1 2026 in Review

D.A. Davidson & Co reduced its Teva Pharmaceuticals (TEVA) stake by 3.5% in Q1 2026, selling an estimated $117K and leaving 101,274 shares worth $3.05M. The position accounts for 0.02% of the portfolio, ranked #552.

D.A. Davidson & Co first reported a position in TEVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.1M in Q2 2013. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • D.A. Davidson & Co held 101,274 shares of Teva Pharmaceuticals worth $3.05M as of Q1 2026.
  • D.A. Davidson & Co sold 3,646 Teva Pharmaceuticals shares in Q1 2026, an estimated $117K.
  • Teva Pharmaceuticals made up 0.02% of D.A. Davidson & Co's portfolio in Q1 2026, its #552 holding.
  • D.A. Davidson & Co first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • D.A. Davidson & Co's Teva Pharmaceuticals position peaked at $10.1M in Q2 2013.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.